FTY720. Immunosuppressant

Drugs of the Future

Volumn 22, Issue 1, 1997, Pages 18-22

  Chiba, Kenji ^a   Adachi, Kunitomo ^a  

^a Yoshitomi Pharmaceutical Industries Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2;

ANIMAL MODEL; ARTHRITIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOG; DRUG SYNTHESIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; RAT; SHORT SURVEY; SKIN TRANSPLANTATION; T LYMPHOCYTE;

EID: 0030888501     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.01.391380     Document Type: Short Survey

References (31)

1. Fujita, T., Sasaki, S., Yoneta, M., Mishina, T., Adachi, K., Chiba, K. (Yoshitomi Pharm. Ind., Ltd., Taito Co., Ltd.). 2-Amino-1,3-propanediol compound and immunosuppressant. EP 627406, JP 94509845, WO 9408943.
2. Adachi, K., Kohara, T., Nakao, N., Arita, M., Chiba, K., Mishina, T., Sasaki, S., Fujita, T. Design, synthesis, and structure activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem Lett 1995, 5: 853-6.
3. Borel, J.F., Feurer, C., Gubler, H.U., Stahelin, H. The biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 1976, 6: 468-75.
4. Borel, J.F., Pharmacology of cyclosporine (Sandimmune) IV. Pharmacological properties in vivo. Pharmacol Rev 1989, 41: 259-371.
5. Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H., Imanaka, H. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 1987, 40: 1249-55.
6. Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H., Ochiai, T. KF-506, a novel immunosuppressant isolated from a Streptomyces II. Immunosuppressive effect of FK-506 in vitro. J Antibiotics 1987, 40: 1256-65.
7. Inamura, N., Nakahara, K., Kino, T., Goto, T., Aoki, H., Yamaguchi, I., Kohsaka, M., Ochiai, T. Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK-506. Transplantation 1988, 45: 206-9.
8. Liu, J., Farmer, J.D. Jr., Lane, W.S., Friedman, J., Weissman, I., Schreiber, S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66: 807-15.
9. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994, 344: 423-8.
10. Slapak, M., Geoghagen, T., Digard, N. et al. The use of ciclosporine in combination with azathioprine and steroids in renal transplantation. Transplant Proc 1985, 17: 1222-6.
11. Kokado, Y., Ishibashi, M., Jiang, H., Takahara, S., Sonoda, T. Low-dose ciclosporin, mizoribine, and prednisolone in renal transplantation: A new triple-drug therapy. Clin Transplant 1990, 4: 191-7.
12. Fujita, T., Inoue, K., Yamamoto, S., Ikumoto, T., Sasaki, S., Toyama, R., Chiba, K., Hoshino, Y., Okumoto, T. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot 1994, 47: 208-15.
13. Sasaki, S., Hashimoto, R., Kiuchi, M., Inoue, K., Ikumoto, T., Hirose, R., Chiba, K., Hoshino, Y., Okumoto, T., Fujita, T. Fungal metabolites. Part 14. Novel potent immunosuppressants, mycestericins, produced by Myceria sterilia. J Antibiot 1994, 47: 420-33.
14. Fujita, T. Inoue, K., Yamamoto, S., Ikumoto, T., Sasaki, S., Toyama, R., Yoneta, M., Chiba, K., Hoshino, Y., Okumoto, T. Fungal metabolites. Part 12. Potent immunosuppressant, 14-deoxomyriocin, (2S,3R,4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives. J Antibiot 1994, 47: 216-24.
15. Fujita, T., Yoneda, M., Hirose, R., Sasaki, S., Inoue, K., Kiuchi, M., Hirase, S., Adachi, K., Arita, M., Chiba, K. Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activity. Bioorg Med Chem Lett 1995, 5: 847-52.
16. Fujita, T., Hirose, R., Yoneta, M., Sasaki, S., Inoue, K., Kiuchi, M., Hirase, S., Chiba, K., Sakamoto, H., Arita, M. Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols. J Med Chem 1996, 39: 4451-9.
17. Chiba, K., Hoshino, Y., Suzuki, C., Masubuchi, Y., Yanagawa, Y., Ohtsuki, M., Sasaki, S., Fujita, T. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rat. Transplant Proc 1996, 28: 1056-9.
18. Kahan, B.D., Tejpal, N., Stubbers, S.G., Tu, Y., Wang, M., Stepkowski, S., Chou, T.C. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination. Transplantation 1993, 55: 894-900.
19. Hoshino, Y., Suzuki, C., Masubuchi, M., Amano, Y., Chiba, K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allograft and synergistic effect in combination with cyclosporine A. Transplant Proc 1996, 28: 1060-1.
20. Kawaguchi, T. Hoshino, Y., Rahman, F. et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant Proc 1996, 28: 1062-3.
21. Suzuki, S., Enosawa, S., Kakefuda, T., Shinomiya, T., Amari, M., Naoe, S., Hoshino, Y., Chiba, K. A novel immunosuppressant, FTY720, having an unique mechanism of action induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996, 61: 200-5.
22. Suzuki, S., Enosawa, S., Kakefuda, T., Amamiya, H., Hoshino, Y., Chiba, K. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Transplant Proc 1996, 28: 1375-6.
23. Davies, H.S., Collier, D.S.J., Thiru, S., Decurtins, M., Calne, R. Y. Long-term survival of kidney allografts in dogs after withdrawal of immunosuppression with ciclosporin and azathioprine. Eur Surg Res 1989, 21: 65-75.
24. Amemiya, H., Suzuki, S., Niiya, S., Watanabe, H., Kotake, T. Synergistic effect of cyclosporine and mizoribine on survival of dog renal allografts. Transplantation 1988, 46: 768-71.
25. Masubuchi, Y., Kawaguchi, T., Ohtsuki, M., Suzuki, C., Amano, Y., Hoshino, Y., Chiba, K. FTY720, a novel immunosuppressant possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. Transplant Proc 1996, 28: 1064-5.
26. Teshima, K., Imayoshi, T., Matsuura, M., Yamaguchi, S., Chiba, K., Terasawa, M. FTY720, a novel immunosuppressant, possessing unique mechanisms. III. Pharmacological activities in several autoimmune and inflammatory models. 9th Int Cong Immunol (July 25-30, San Francisco) 1995, Abst 5127.
27. Chiba, K., Teshima, K., Fujii, A., Masubuchi, Y., Suzuki, C., Adachi, K., Mishina, T., Sasaki, S., Fujita, T. FTY720, a novel immunosuppressant, possessing unique mechanisms. I. Relationship between immunosuppressive effects and selective decrease of peripheral mature T cells. 9th Int Cong Immunol (July 25-30, San Francisco) 1995, Abst 5125.
28. Arbones, M.L., Ord, D.C., Ley, K., Ratech, H., Curry, C.M., Otten, G., Capon, D.J., Tedder, T. F. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994, 1: 247-60.
29. 4-integrins in lymphocyte homing to mucosal tissue in vivo. J Immunol 1994, 152: 3282-93.
30. Imai, Y., Lasky, L.A., Rosen, S.D. Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature 1993, 361: 555-7.
31. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993, 74: 185-95.